Analysis Life Sciences Thank You The cost of artificially short expiration dates: Worsened shortages, higher costs and more waste
Agency IQ
JANUARY 26, 2024
Such a situation is commonplace in the clinical trial realm, in which investigational drug products which are not already FDA approved are administered to patients. Under the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA) , the FDA also has some authority to extend MCM expiration dates.
40 
Let's personalize your content